Call Options Transactions Made in Q2 2024 in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during Q2 2024. The information is specifically focused on institutions that hold call options of Ultragenyx Pharmaceutical Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
BUY
|
CALL |
144K+ 480.0% |
$5.39M - $7.43M
|
174K
$7.79M
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
33.6K+ 25.47% |
$1.26M - $1.73M
|
166K
$7.41M
|
|
|
Aug 14, 2024
Q2 2024
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
CALL |
29.3K+ 273.83% |
$1.1M - $1.51M
|
40K
$1.79M
|
|
|
Aug 14, 2024
Q2 2024
|
Moore Capital Management, LP
New York, NY |
BUY
|
CALL |
25K+ 33.33% |
$936K - $1.29M
|
100K
$4.48M
|
|
|
Aug 14, 2024
Q2 2024
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
2.4KNew |
$89.8K - $124K
|
2.4K
$107K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-7.4K- 24.03% |
$277K - $382K
|
23.4K
$1.05M
|